Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability

Conclusion: In our opinion, replacing liver microsome and hepatocyte assays with S9 assay for high throughput metabolic screening purposes provides the combined benefit of comprehensive and high quality data at a reasonable expense for drug discovery programs.
Source: Drug Metabolism Letters - Category: Drugs & Pharmacology Source Type: research